Clinical Trial

Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas

Name: Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas — clinical trial record (NCT07506161)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-03-27.

Trial Details

NCT Number	NCT07506161
Lead Sponsor	Premier G Med Cardio Kft Collaborators: Ministry of Innovation and Technology, Hungary, Semmelweis University
Conditions	Papillary Thyroid Microcarcinoma
Enrollment	27 participants
Start Date	2021-09-09
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-09